Unsuccessful Dasatinib Therapy in a Refractory Patient with Chronic Lymphocytic Leukemia

Publisher： Karger

E-ISSN： 1421-9662|124|2|103-104

ISSN： 0001-5792

Source： Acta Haematologica, Vol.124, Iss.2, 2010-08, pp. : 103-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

Successful Treatment of Refractory Guillain-Barré Syndrome with Alemtuzumab in a Patient with Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-05 ,pp. : 240-243

Karger

Access to resources Recommend Favorite

Comparison of the Effects of Two Kinase Inhibitors, Sorafenib and Dasatinib, on Chronic Lymphocytic Leukemia Cells

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 420-426

Karger

Access to resources Recommend Favorite

Dasatinib in the Treatment of Chronic Myeloid Leukemia

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 1, 2011-01 ,pp. : 99-105

Bentham Science Publishers

Access to resources Recommend Favorite

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 179-179

John Wiley & Sons Inc

Access to resources Recommend Favorite